P Beris - Concepedia

Author

P Beris

University Hospital of Geneva

Also Known As

P Beris, P. Beris, PH. BERIS, Ph. Beris

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Geneva Hôpital Beau-Séjour

About

P Beris is an author at University Hospital of Geneva specializing in hematology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	93
2	Pathology	3	3	92
3	Health Sciences	1	1	23
4	Cell Biology	1	1	29
5	Immunology	1	1	23

P Beris

Publications

493

Citations

H-Index

Page 1

	Year	Citations
Adoptive immunotherapy for recurrent CML after BMT. Claudine Helg, Étienne Roux, P Beris, PubMed	1993	71
Inclusion body beta-thalassemia trait in a Swiss family is caused by an abnormal hemoglobin (Geneva) with an altered and extended beta chain carboxy-terminus due to a modification in codon beta 114 P Beris, PA Miescher, JC Diaz-Chico, Blood	1988	51
Haplotypes and α globin gene analyses in sickle cell anaemia patients from Kenya Peter Ojwang, T. Ogada, P Beris, British Journal of Haematology	1987	49
Primary clonal myelodysplastic syndromes. P Beris PubMed Hematological MalignancyHematologyPathologyMyelopoiesisMyeloid Neoplasia	1989	49
Inclusion body beta-thalassemia trait in a Swiss family is caused by an abnormal hemoglobin (Geneva) with an altered and extended beta chain carboxy-terminus due to a modification in codon beta 114 P Beris, PA Miescher, JC Diaz-Chico, Blood	1988	48
Haemoglobin Tunis‐Bizerte: a new <i>a</i> globin 129 Leu–> Pro unstable variant with thalassaemic phenotype R Darbellay, Sara Mach‐Pascual, Karen E. Rose, British Journal of Haematology	1995	30
Lentiviral PU.1 overexpression restores differentiation in myeloid leukemic blasts Stéphane Durual, A Rideau, Sylvie Ruault-Jungblut, Leukemia Hematological MalignancyLentiviral Pu.1 OverexpressionHematologyCell BiologyMyelopoiesis	2007	29
Primary acquired sideroblastic and primary acquired refractory anemia. P Beris, Graf Bj, Miescher Pa PubMed AnemiaHematologyRefractory AnemiaPathologyMedicine	1983	25
Malignant histiocytosis in the leukaemic stage: a new entity (M5c-AML) in the FAB classification? F M Laurencet, B Chapuis, P Roux‐Lombard, PubMed	1994	24
Autoimmune hemolytic anemia and/or thrombocytopenia associated with lupus parameters. Miescher Pa, Alessandra Tucci, P Beris, PubMed ImmunohematologyAutoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus TreatmentLupus	1992	23

Page 1